InvestorQ : When is the Bharat Biotech vaccine expected to hit the market?
Ria Jain made post

When is the Bharat Biotech vaccine expected to hit the market?

Answer
image
Dia Deshpande answered.
11 months ago
Follow

Bharat Biotech announced licensing agreement with Washington School of Medicine for a novel chimpanzee adenovirus-based single dose intranasal vaccine for COVID-19. Bharat Biotech will have rights to distribute the vaccine outside of the US, Europe and Japan.

Phase-I trials will be done at the Vaccine Evaluation Unit of Washington University. Bharat Biotech will undertake further stages of clinical trials and also manufacture the vaccine at its facility in Genome Valley, Hyderabad. Bharat Biotech plans to scale to 1 billion doses.

Meanwhile, Bharat Biotech is simultaneously conducting a Phase-2 trial on a wholly inactivated virus vaccine which it co-developed with the National Institute of Virology affiliated to ICMR.

1 Views